MCP Server For Financial Data by EODHD Learn more

Immunovant Inc (IMVT NASDAQ) stock market data APIs

$23.4642 0.93(4%)
as of November 18, 2025
Try our APIs with free plan!

Immunovant Inc Financial Data Overview

Price chart is built with Anychart
OpenFigi: BBG00P5M**** The data is available with plans that include the Fundamentals API. Check our pricing page for details. CIK: 000176**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Prev. Close 23.4642
Open 24.3962
High 24.3962
Low 23.4523
52 wk Range 12.72-29.49
Market Cap 4 152 M
Shares Outstanding 175 M
EPS -0.73
Beta 0.556

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Immunovant Inc (top by weight)

Ticker
100-day Price Change
Weight
NIXT.US Research Affiliates Deletions ETF
0.45 (1.88%)
0.86
BBC.US Virtus LifeSci Biotech Clinical Trials ETF
12.7 (60.29%)
0.83
TMED.US T. Rowe Price Health Care ETF
5.6 (23.58%)
0.48
XBI.US SPDR® S&P Biotech ETF
30.04 (35.29%)
0.47
BTEC.SW iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) USD
1.54 (23.54%)
0.35
2B70.F iShares NASDAQ US Biotechnology UCITS ETF
1.43 (25.53%)
0.35
2B70.XETRA iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
1.38 (24.44%)
0.35

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Immunovant Inc data using free add-ons & libraries


Get Immunovant Inc Fundamental Data

Immunovant Inc Fundamental data includes:

  • Net Revenue:
  • EBITDA: -486 694 016
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Immunovant Inc Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2025-11-10
  • EPS/Forecast: -0.71
GET THE PACKAGE

Get Immunovant Inc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat

Send the request

Leave your email and our team will contact you ASAP.